Invesaro

Stocks LITS Financial statements

Financial statements

Lite Strategy, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Lite Strategy, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue23.21.624.9227.834.840.748.865.30
Cost of revenue53.384.262.671.410
Gross profit18.2-1.760.6525.133.440.7
Research and development13.47.241732.334.169.485.652.516.63.92
General and administrative7.68.639.7914.616.724.430.533.123.313.5
Operating expenses21
Operating income-212.38-28.6-46.2-25.7-60.4-75.5-36.814.5-17.5
Interest income0.140.290.591.81.40.510.283.353.281.03
Other non-operating income0-21.519.1214.933.241.51
Pre-tax income-20.92.67-40.1-16.8-47.2-41.3-54.5-31.817.8-15.9
Income tax000000.010000
Net income-20.92.67-40.1-16.8-47.2-41-54-3217.8-15.9
EBITDA-20.92.47-28.5-46.2-25.6-60.1-75.2-36.414.9-17.1
EPS, basic-12.191.40-19.38-4.80-10.39-7.39-8.75-4.782.67-2.39
EPS, diluted-12.191.40-19.38-14.99-10.39-11.99-9.99-4.782.67-2.39
Shares, basic (weighted)1.721.842.073.564.565.636.226.666.666.66
Shares, diluted (weighted)1.721.852.073.624.565.736.266.666.666.66
Dividend per share1.75

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents10.88.4613.39.5912.38.5415.716.93.7118
Short-term investments35.145.189.464.917014513883.834.60
Receivables00000
Other current assets0.831.761.592.442.743.813.836.752.420.27
Total current assets46.755.310482.220916516710840.818.3
Property, plant and equipment0.050.050.030.21.081.511.661.310.390
Lease right-of-use assets07.779.05120.210
Intangible assets0.370.330.30.26
Other non-current assets0
Total assets47.255.710582.721017417812141.418.3
Accounts payable1.080.593.644.792.446.367.926.133.170.18
Accrued liabilities4.433.293.454.566.098.410.812.55.191.18
Deferred revenue10.794.965.234.534.830.320
Total current liabilities5.514.877.8914.313.820.224.420.38.361.35
Lease liabilities07.378.7711.30
Total liabilities5.514.8754.234.713312512596.28.361.35
Paid-in capital219225265279355369427431421421
Retained earnings-177-174-214-231-278-320-374-406-388-404
Treasury stock0
Shareholders' equity41.750.850.547.977.149.552.424.63316.9
Total equity41.750.850.547.977.149.552.424.63316.9
Total liabilities and equity47.255.710582.721017417812141.418.3
Shares outstanding1.711.843.523.685.585.646.666.666.666.66

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-20.92.67-40.1-16.8-47.2-41.3-54.5-31.817.8-15.9
Depreciation and amortization0.060.090.050.080.110.290.330.390.380.37
Stock-based compensation2.722.33.226.566.810.28.353.592.28-0.14
Change in receivables-0.2-2.35-4.72
Cash from operations-17.93.49-21-29.434.3-32-48.7-52.5-50.5-20.8
Capital expenditures-0-0.05-0.22-0.89-0.71-0.48-0.04-0.010
Purchases of investments-55.2-60.1-114-64.7-190-420-273-102-58.20
Cash from investing9.97-10.1-44.324.3-10624.76.8953.749.135.2
Stock issued4.210.330.37733.252.30
Dividends paid0-11.70
Cash from financing4.2170.21.3974.83.4749.1-0.04-11.90
Net change in cash-7.89-2.384.85-3.722.74-3.797.21.17-13.214.3
Free cash flow-17.93.44-29.633.4-32.7-49.2-52.5-50.5-20.8
Income taxes paid-0-0-0-0-0-0.010

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $1.44 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Return on equity (ROE)-107.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-105.2%Net income / average total assets.
Return on invested capital (ROIC)-93.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-100.0%Revenue vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y-220.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-214.5%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-189.7%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-189.5%EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-48.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-31.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-26.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-55.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-53.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-38.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y7.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio11.5xCurrent assets / current liabilities.
Quick ratio7.92x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio7.92x(Cash + short-term investments) / current liabilities.
Liabilities / assets1.6%Total liabilities / total assets.
Working capital$10.0MCurrent assets - current liabilities.
Tangible book value$56.8MShareholders' equity - goodwill - intangible assets.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.70Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share-$0.29Cash from operations / diluted weighted shares.
Book value per share$1.62Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.62Tangible book value / shares outstanding.
Cash per share$0.21(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$49.0MShare price x shares outstanding.
Enterprise value$41.5MMarket cap + total debt - cash - short-term investments.
P/B0.86xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.86xMarket cap / tangible book value, when positive.
Earnings yield-124.1%Net income / market cap (the inverse of P/E).
What was Lite Strategy, Inc.'s revenue in fiscal 2025?

Lite Strategy, Inc. reported revenue of $0.0 for fiscal 2025, 100% lower than the year before.

Was Lite Strategy, Inc. profitable in fiscal 2025?

No. It reported a net loss of $15.9M.

How much free cash flow did Lite Strategy, Inc. generate in fiscal 2025?

Cash from operations of $20.8M minus capital expenditures of $0.0 left free cash flow of -$20.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Lite Strategy, Inc.